About Progenerics Pharma Private Limited
Data last updated:
Progenerics Pharma Private Limited is a private limited company based in Patancheru, Telangana, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 05 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2015PTC102075. Its GSTIN is 36AAICP3776B1ZD (Telangana).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.83 Cr. It is led by directors including Mamilla Nagarjun Reddy and Sandeep Kondapalli Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.73A Export Promotion Industrial Park Pashamylarm, Patancheru, Telangana, India – 502307.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.96 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net loss of ₹1.46 Cr (net margin -49.4%) and EBITDA of -₹58.1 Lakh (EBITDA margin -19.6%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 12% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Progenerics Pharma. As per MCA filings, the company has satisfied charges of ₹5 Cr on record. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.98 Cr; the latest was in January 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Aishika Pharma Private Limited with revenue of ₹3 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website progenericspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.73A Export Promotion Industrial Park Pashamylarm, Patancheru, Telangana, India – 502307
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Progenerics Pharma Private Limited
The main business activity of Progenerics Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Progenerics Pharma Private Limited FY 2025 filings available
Progenerics Pharma Private Limited reported revenue of ₹2.96 Cr (up 70% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Progenerics Pharma Private Limited
Revenue rose 70% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Progenerics Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹58.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.46 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Progenerics Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -49.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Progenerics Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Progenerics Pharma Private Limited
Progenerics Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aishika Pharma Private Limited | ₹3 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Icon Formulations Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Hyderabad, Telangana, India |
| Realmed Pharma Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chandigarh, India |
| Spectrum Pharmachem Private Limited | ₹2.99 Cr (FY 2024) | •••• | •••• | 1495500.0% | •••• | Palghar, Maharashtra, India |
| Fuzen Pharmaceuticals Private Limited | ₹2.98 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Indore, Madhya Pradesh, India |
| Progenerics Pharma Private Limited this company | ₹2.96 Cr (FY 2025) | •••• | •••• | 70.0% | •••• | Patancheru, Telangana, India |
| Azius Pharma Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | New Delhi, Delhi, India |
| Orionex Formulations Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Protech Biopharma Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | -39.0% | •••• | Srinagar, Jammu and Kashmir, India |
| Aajivika Enterprises Private Limited | ₹2.94 Cr (FY 2025) | •••• | •••• | 548.0% | •••• | Varanasi, Uttar Pradesh, India |
| GMH Pharmaceuticals Pvt Ltd | ₹2.94 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Progenerics Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Progenerics Pharma Private Limited
Progenerics Pharma Private Limited is audited by Ramayanam & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ramayanam & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Progenerics Pharma Private Limited
Progenerics Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mamilla Nagarjun Reddy Also directs: Kryn Enterprises LLP, Vainavin Lifesciences Private Limited | Additional Director | 30 Dec 2024 | 1 Years 9 Months | Current |
| Sandeep Kondapalli Reddy Also directs: Vainavin Lifesciences Private Limited | Additional Director | 30 Dec 2024 | 1 Years 9 Months | Current |
| Kotla Suraj Reddy | Additional Director | 30 Dec 2024 | 1 Years 9 Months | Current |
Ownership and Shareholding of Progenerics Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Progenerics Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2016 | Others | ₹5 Cr | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Progenerics Pharma Private Limited
Progenerics Pharma Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.98 Cr; the latest was in January 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Feb 2017 | Funding round | ₹2.62 Cr | Investors: 3 individuals |
| Jan 2016 | Funding round | ₹4.37 Cr | Investors: 4 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Progenerics Pharma Private Limited
Progenerics Pharma operates one associated brand: Progenerics Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers formulation and analytical development services for pharmaceutical customers. | progenericspharma.com |
Employees and EPFO Compliance at Progenerics Pharma Private Limited
Progenerics Pharma Private Limited has a workforce of 27 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Progenerics Pharma Private Limited
Progenerics Pharma Private Limited has 8 board changes on record since 2015: 5 appointments and 3 cessations. The latest: Kotla Suraj Reddy was appointed as Additional Director on 30 Dec 2024.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Progenerics Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Progenerics Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Progenerics Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Progenerics Pharma Private Limited
Progenerics Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICP3776B1ZD | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Progenerics Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Progenerics Pharma Private Limited
Progenerics Pharma is an active private limited company based in Patancheru, Telangana, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 05 December 2015 (11+ years old) and is registered under CIN U24233TG2015PTC102075.
Progenerics Pharma reported revenue of ₹2.96 Cr for FY 2025 (up 70% YoY).
Progenerics Pharma has 3 current directors:
- Mamilla Nagarjun Reddy - Additional Director
- Sandeep Kondapalli Reddy - Additional Director
- Kotla Suraj Reddy - Additional Director
Progenerics Pharma reported a net loss of ₹1.46 Cr (net margin -49.4%) and EBITDA of -₹58.1 Lakh (EBITDA margin -19.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Progenerics Pharma is -29% over three years and -12% over five years. In the latest year (FY 2025) revenue rose 70%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Progenerics Pharma is 36AAICP3776B1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Progenerics Pharma is U24233TG2015PTC102075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Progenerics Pharma was incorporated on 05 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Progenerics Pharma has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.98 Cr; the latest was in January 2018.
The peers of Progenerics Pharma by revenue are Aishika Pharma Private Limited, Icon Formulations Private Limited, Realmed Pharma Private Limited, Spectrum Pharmachem Private Limited, Fuzen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Kotla Suraj Reddy was appointed as Additional Director on 30 Dec 2024. Mamilla Nagarjun Reddy was appointed as Additional Director on 30 Dec 2024. Sandeep Kondapalli Reddy was appointed as Additional Director on 30 Dec 2024. Progenerics Pharma has 8 board changes on record in total.